Binding site-based classification of coronaviral papain-like proteases

Proteins: Structure, Function and Genetics

Volumn 62, Issue 3, 2006, Pages 760-775

  Sulea, Traian ^a   Lindner, Holger A ^a   Purisima, Enrico O ^a   Ménard, Robert ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Annotation; Coronavirus; Fold recognition; Inhibition; Processing site; Ubiquitin specific protease

Indexed keywords

PAPAIN; PAPAIN LIKE PROTEASE; POLYPROTEIN; PROTEIN PL1PRO; PROTEIN PL2PRO; PROTEINASE; REPLICASE; UBIQUITIN SPECIFIC PROTEASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; ENZYME BINDING; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE REPLICATION; GENE STRUCTURE; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; SARS CORONAVIRUS; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS GENOME;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATTLE; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; CORONAVIRUS; MOLECULAR SEQUENCE DATA; PAPAIN; PEPTIDE HYDROLASES; SEQUENCE ALIGNMENT; SWINE; VIRAL PROTEINS;

CORONAVIRUS; SARS CORONAVIRUS;

EID: 31944451605     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.20802     Document Type: Article

References (65)

1. Cavanagh D. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Virol 1997;142:629-633.
2. Ziebuhr J, Siddell SG. Nidoviruses. In: Atlas R, Bynum WF, Cox M, editors. Encyclopedia of life sciences. London: Stockton Press; 2002. p 190-198.
3. Lai MM, Holmes KV. Coronaviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins; 2001. p 1163-1185.
4. Holmes KV. Coronaviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins; 2001. p 1187-1203.
5. Fouchier RAM, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon JH, Osterhaus ADME. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 2004;101:6212-6216.
6. van der Hoek L, Pyre K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J, Berkhout B. Identification of a new human coronavirus. Nat Med 2004;10:368-373.
7. Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 2005;191:492-498.
8. Woo PCY, Lau SKP, Chu Cm, Chan Kh, Tsoi Hw, Huang Y, Wong BHL, Poon RWS, Cai JJ, Luk Wk, Poon LLM, Wong SSY, Guan Y, Peiris JSM, Yuen Y. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005;79:884-895.
9. Skowronski DM, Astell C, Brunham RC, Low DE, Petric M, Roper RL, Talbot PJ, Tam T, Babiuk L. Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 2005;56:357-381.
10. Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, Chen QX, Gao YW, Zhou HQ, Xiang H, Zheng HJ, Chern SWW, Cheng F, Pan CM, Xuan H, Chen SJ, Luo HM, Zhou DH, Liu YF, He JF, Qin PZ, Li LH, Ren YQ, Liang WJ, Yu YD, Anderson L, Wang M, Xu RH, Wu XW, Zheng HY, Chen JD, Liang G, Gao Y, Liao M, Fang L, Jiang LY, Li H, Chen F, Di B, He LJ, Lin JY, Tong S, Kong X, Du L, Hao P, Tang H, Bernini A, Yu XJ, Spiga O, Guo ZM, Pan HY, He WZ, Manuguerra JC, Fontanet A, Danchin A, Niccolai N, Li YX, Wu CI, Zhao GP. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci USA 2005;102:2430-2435.
11. Oxford JS, Balasingam S, Chan C, Catchpole A, Lambkin R. New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus. Antivir Chem Chemother 2005;16:13-21.
12. Sung JJ, Wu A, Joynt GM, Yuen KY, Lee N, Chan PK, Cockram CS, Ahuja AT, Yu LM, Wong VW, Hui DS. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 2004;59:414-420.
13. Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, Kao RY, Poon LL, Wong CL, Guan Y, Peiris JS, Yuen KY. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004;59:252-256.
14. Ziebuhr J. The coronavirus replicase. Curr Top Microbiol Immunol 2005;287:57-94.
15. Ziebuhr J, Snijder EJ, Gorbalenya AE. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol 2000;81:853-879.
16. Brockway SM, Lu XT, Peters TR, Dermody TS, Denison MR. Intracellular localization and protein interactions of the gene 1 protein p28 during mouse hepatitis virus replication. J Virol 2004;78:11551-11562.
17. Prentice E, McAuliffe J, Lu X, Subbarao K, Denison MR. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. J Virol 2004;78:9977-9986.
18. Salonen A, Ahola T, Kaariainen L. Viral RNA replication in association with cellular membranes. Curr Top Microbiol Immunol 2005;285:139-173.
19. Herold J, Thiel V, Siddell SG. Characterization of a papain-like cysteine-proteinase encoded by gene 1 of the human coronavirus HCV 229E. Adv Exp Med Biol 1998;440:141-147.
20. Lim KP, Ng LFP, Liu DX. Identification of a novel cleavage activity of the first papain-like proteinase domain encoded by open reading frame 1a of the coronavirus avian infectious bronchitis virus and characterization of the cleavage products. J Virol 2000;74:1674-1685.
21. Ziebuhr J, Thiel V, Gorbalenya AE. The autocatalytic release of a putative RNA virus transcription factor from its polyprotein precursor involves two paralogous papain-like proteases that cleave the same peptide bond. J Biol Chem 2001;276:33220-33232.
22. Thiel V, Ivanov KA, Putics A, Hertzig T, Schelle B, Bayer S, Weissbrich B, Snijder EJ, Rabenau H, Doerr HW, Gorbalenya AE, Ziebuhr J. Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol 2003;84:2305-2315.
23. Kanjanahaluethai A, Jukneliene D, Baker SC. Identification of the murine coronavirus MP1 cleavage site recognized by papain-like proteinase 2. J Virol 2003;77:7376-7382.
24. Teng H, Weiss SR. Further in vitro characterization of mouse hepatitis virus papain-like proteinase 1: cleavage sequence requirements within ppla. J Neurovirol 2002;8:143-149.
25. Harcourt BH, Jukneliene D, Kanjanahaluethai A, Bechill J, Severson KM, Smith CM, Rota PA, Baker SC. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol 2004;78:13600-13612.
26. Rawlings ND, Tolle DP, Barrett AJ. MEROPS: the peptidase database. Nucleic Acids Res 2004;32:D160-D164.
27. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LLM, Guan Y, Rozanov M, Spaan WJM, Gorbalenya AE. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 2003;331:991-1004.
28. Gosert R, Kanjanahaluethai A, Egger D, Bienz K, Baker SC. RNA Replication of mouse hepatitis virus takes place at double-membrane vesicles. J Virol 2002;76:3697-3708.
29. Perlman S, Ries D, Bolger E, Chang LJ, Stoltzfus CM. MHV nucleocapsid synthesis in the presence of cycloheximide and accumulation of negative strand MHV RNA. Virus Res 1986;6:261-272.
30. Sawicki SG, Sawicki DL. Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis. J Virol 1986;57:328-334.
31. Kim JC, Spence RA, Currier PF, Lu X, Denison MR. Coronavirus protein processing and RNA synthesis is inhibited by the cysteine proteinase inhibitor E64d. Virology 1995;208:1-8.
32. Denison MR, Yount B, Brockway SM, Graham RL, Sims AC, Lu X, Baric RS. Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replication. J Virol 2004;78:5957-5965.
33. Teng H, Pinon JD, Weiss SR. Expression of murine coronavirus recombinant papain-like proteinase: efficient cleavage is dependent on the lengths of both the substrate and the proteinase polypeptides. J Virol 1999;73:2658-2666.
34. Dong S, Baker SC. Determinants of the p28 cleavage site recognized by the first papain-like cysteine proteinase of murine coronavirus. Virology 1994;204:541-549.
35. Hughes SA, Bonilla PJ, Weiss SR. Identification of the murine coronavirus p28 cleavage site. J Virol 1995;69:809-813.
36. Bonilla PJ, Hughes SA, Weiss SR. Characterization of a second cleavage site and demonstration of activity in trans by the papain-like proteinase of the murine coronavirus mouse hepatitis virus strain A59. J Virol 1997;71:900-909.
37. Herold J, Gorbalenya AE, Thiel V, Schelle B, Siddell SG. Proteolytic processing at the amino terminus of human coronavirus 229E gene 1-encoded polyproteins: identification of a papain-like proteinase and its substrate. J Virol 1998;72:910-918.
38. Lim KP, Liu DX. Characterization of the two overlapping papain-like proteinase domains encoded in gene 1 of the coronavirus infectious bronchitis virus and determination of the C-terminal cleavage site of an 87-kDa protein. Virology 1998;245:303-312.
39. Herold J, Siddell SG, Gorbalenya AE. A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold. J Biol Chem 1999;274:14918-14925.
40. Sulea T, Lindner HA, Purisima EO, Menard R. Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease? J Virol 2005;79:4550-4551.
41. Krishna SS, Grishin NV. The finger domain of the human deubiquitinating enzyme HAUSP is a zinc ribbon. Cell Cycle 2004;3:1046-1049.
42. Bujnicki JM, Elofsson A, Fischer D, Rychlewski L. Structure prediction meta server. Bioinformatics 2001;17:750-751.
43. Ginalski K, Elofsson A, Fischer D, Rychlewski L. 3D-Jury: a simple approach to improve protein structure predictions. Bioinformatics 2003;19:1015-1018.
44. Ginalski K, Rychlewski L. Detection of reliable and unexpected protein fold predictions using 3D-Jury. Nucleic Acids Res 2003;31:3291-3292.
45. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
46. Rost B. Protein secondary structure prediction continues to rise. J Struct Biol 2001;134:204-218.
47. Jones DT. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 1999;292:195-202.
48. Karplus K, Barrett C, Hughey R. Hidden Markov models for detecting remote protein Viomologies. Bioinformatics 1998;14:846-856.
49. Albrecht M, Tosatto SCE, Lengauer T, Valle G. Simple consensus procedures are effective and sufficient in secondary structure prediction. Protein Eng 2003;16:459-462.
50. Blundell T, Carney D, Gardner S, Hayes F, Howlin B, Hubbard T, Overington J, Singh DA, Sibanda BL, Sutcliffe M. Knowledge-based protein modelling and design. Eur J Biochem 1988;172:513-520.
51. Hu M, Li P, Li M, Li W, Yao T, Wu JW, Gu W, Cohen RE, Shi Y. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 2002;111:1041-1054.
52. Guarne A, Hampoelz B, Glaser W, Carpena X, Tormo J, Fita I, Skern T. Structural and biochemical features distinguish the foot-and-mouth disease virus leader proteinase from other papain-like enzymes. J Mol Biol 2000;302:1227-1240.
53. Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T1 Caldwell JW, Kollman PA. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc;117:5179-5197.
54. Guarne A, Tormo J, Kirchweger R, Pfistermueller D, Fita I, Skern T. Structure of the foot-and-mouth disease virus leader protease: a papain-like fold adapted for self-processing and eIF4G recognition. EMBO J 1998;17:7469-7479.
55. Andreeva A, Howorth D, Brenner SE, Hubbard TJP, Chothia C, Murzin AG. SCOP database in 2004: refinements integrate structure and sequence family data. Nucleic Acids Res 2004;32:D226-D229.
56. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003;300:1763-1767.
57. Bromme D, Bonneau PR, Lachance P, Storer AC. Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity. J Biol Chem 1994;269:30238-30242.
58. Fox T, Mason P, Storer AC, Mort JS. Modification of S1 subsite specificity in the cysteine protease cathepsin B. Protein Eng 1995;8:53-57.
59. Quesada V, Diaz-Perales A, Gutierrez-Fernandez A, Garabaya C, Cal S, Lopez-Otin C. Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. Biochem Biophys Res Commun 2004;314:54-62.
60. Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 2004;1695:189-207.
61. Kanjanahaluethai A, Baker SC. Identification of mouse hepatitis virus papain-like proteinase 2 activity. J Virol 2000;74:7911-7921.
62. Varughese KI, Su Y, Cromwell D, Hasnain S, Xuong NH. Crystal structure of an actinidin-E-64 complex. Biochemistry 1992;31:5172-5176.
63. Zhao B, Janson CA, Amegadzie BY, D'Alessio K, Griffin C, Hanning CR, Jones C, Kurdyla J, McQueney M, Qiu X, Smith WW, Abdel-Meguid SS. Crystal structure of human osteoclast cathepsin K complex with E-64. Nat Struct Biol 1997;4:109-111.
64. Gonzalez JM, Gomez-Puertas P, Cavanagh D, Gorbalenya AE, Enjuanes L. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol 2003;148:2207-2235.
65. Min J, Landry J, Sternglanz R, Xu RM. Crystal structure of a SIR2 homolog-NAD complex. Cell 2001;105:269-279.